|
Secondary prevention
Citations 51-60 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Coronary Heart Disease
Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors
- Peter Collins, Lori Mosca, Mary Jane Geiger, Deborah Grady, Marcel Kornitzer, Messan G. Amewou-Atisso, Mark B. Effron, Sherie A. Dowsett, Elizabeth Barrett-Connor, and Nanette K. Wenger
Circulation 2009;119:922-930; published online before print as doi:10.1161/CIRCULATIONAHA.108.817577
[Abstract]
[Full text]
- Controversies in Cardiovascular Medicine
Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis
- Paul S. Teirstein
Circulation 2009;119:1021-1033, doi:10.1161/CIRCULATIONAHA.107.759712
[Full text]
- Articles
Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial. Results of Subgroup Analyses by Age and Other Factors
- Peter Collins, Lori Mosca, Mary Jane Geiger, Deborah Grady, Marcel Kornitzer, Messan G. Amewou-Atisso, Mark B. Effron, Sherie A. Dowsett, Elizabeth Barrett-Connor, and Nanette K. Wenger
Circulation published February 9, 2009, doi:10.1161/CIRCULATIONAHA.108.817577
[Abstract]
- Editorials
Copayment Levels and Medication Adherence: Less Is More
- Niteesh K. Choudhry
Circulation 2009;119:365-367, doi:10.1161/CIRCULATIONAHA.108.829655
[Full text]
- Arrhythmia/Electrophysiology
High Efficacy of β-Blockers in Long-QT Syndrome Type 1: Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of β-Blocker Treatment "Failures"
- G. Michael Vincent, Peter J. Schwartz, Isabelle Denjoy, Heikki Swan, Candice Bithell, Carla Spazzolini, Lia Crotti, Kirsi Piippo, Jean-Marc Lupoglazoff, Elizabeth Villain, Silvia G. Priori, Carlo Napolitano, and Li Zhang
Circulation 2009;119:215-221; published online before print as doi:10.1161/CIRCULATIONAHA.108.772533
[Abstract]
[Full text]
- Coronary Heart Disease
Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay: A 12-Month Follow-Up
- Rossella Marcucci, Anna Maria Gori, Rita Paniccia, Betti Giusti, Serafina Valente, Cristina Giglioli, Piergiovanni Buonamici, David Antoniucci, Rosanna Abbate, and Gian Franco Gensini
Circulation 2009;119:237-242; published online before print as doi:10.1161/CIRCULATIONAHA.108.812636
[Abstract]
[Full text]
- Articles
Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay. A 12-Month Follow-Up
- Rossella Marcucci, Anna Maria Gori, Rita Paniccia, Betti Giusti, Serafina Valente, Cristina Giglioli, Piergiovanni Buonamici, David Antoniucci, Rosanna Abbate, and Gian Franco Gensini
Circulation published December 31, 2008, doi:10.1161/CIRCULATIONAHA.108.812636
[Abstract]
- Articles
High Efficacy of  -Blockers in Long-QT Syndrome Type 1. Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of -Blocker Treatment "Failures"
- G. Michael Vincent, Peter J. Schwartz, Isabelle Denjoy, Heikki Swan, Candice Bithell, Carla Spazzolini, Lia Crotti, Kirsi Piippo, Jean-Marc Lupoglazoff, Elizabeth Villain, Silvia G. Priori, Carlo Napolitano, and Li Zhang
Circulation published December 31, 2008, doi:10.1161/CIRCULATIONAHA.108.772533
[Abstract]
- Health Services and Outcomes Research
Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction
- Hani Jneid, Gregg C. Fonarow, Christopher P. Cannon, Adrian F. Hernandez, Igor F. Palacios, Andrew O. Maree, Quinn Wells, Biykem Bozkurt, Kenneth A. LaBresh, Li Liang, Yuling Hong, L. Kristin Newby, Gerald Fletcher, Eric Peterson, Laura Wexler for the Get With the Guidelines Steering Committee and Investigators
Circulation 2008;118:2803-2810; published online before print as doi:10.1161/CIRCULATIONAHA.108.789800
[Abstract]
[Full text]
- Coronary Heart Disease
Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis: Insights From ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation)
- Stephen J. Nicholls, E. Murat Tuzcu, Danielle M. Brennan, Jean-Claude Tardif, and Steven E. Nissen
Circulation 2008;118:2506-2514; published online before print as doi:10.1161/CIRCULATIONAHA.108.790733
[Abstract]
[Full text]
|
|
